Skip to Main content
Number of documents

34

Secher Thomas


Journal articles32 documents

  • Giuseppe Sautto, Yuan Tian, Nathalie Heuzé-Vourc', Thomas Secher, Alexie Mayor, et al.. Inhalation of Immuno-Therapeutics/- Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!. Frontiers in Immunology, Frontiers, 2019, 1, ⟨10.3389/fimmu.2019.02760⟩. ⟨hal-02439828⟩
  • Thomas Secher, Emilie Dalonneau, Marion Ferreira, Christelle Parent, Nicolas Azzopardi, et al.. In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration. Journal of Controlled Release, Elsevier, 2019, 303, pp.24-33. ⟨10.1016/j.jconrel.2019.04.005⟩. ⟨hal-02179896⟩
  • Nadine Waldschmitt, Sho Kitamoto, Thomas Secher, Vassiliki Zacharioudaki, Olivier Boulard, et al.. The regenerating family member 3 β instigates IL-17A-mediated neutrophil recruitment downstream of NOD1/2 signalling for controlling colonisation resistance independently of microbiota community structure. Gut, BMJ Publishing Group, In press, in oress, pp.gutjnl-2018-316757. ⟨10.1136/gutjnl-2018-316757⟩. ⟨hal-02126570⟩
  • Clémence Massip, Priscilla Branchu, Nadège Bossuet-Greif, Camille Chagneau, Déborah Gaillard, et al.. Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917. PLoS Pathogens, Public Library of Science, 2019, 15 (9), pp.e1008029. ⟨10.1371/journal.ppat.1008029⟩. ⟨inserm-02320208⟩
  • N Heuzé-Vourc'h, T. Secher, L. Guilleminault, K. Reckamp, I. Amanam, et al.. Therapeutic antibodies: A new era in the treatment of respiratory diseases?. Pharmacology and Therapeutics, Elsevier, 2018, 189, pp.149-172. ⟨10.1016/j.pharmthera.2018.05.003⟩. ⟨hal-02439820⟩
  • N Heuzé-Vourc'h, A. Guillon, T. Secher, L.A. Dailey, L. Vecellio, et al.. Insights on animal models to investigate inhalation therapy: Relevance for biotherapeutics. International Journal of Pharmaceutics, Elsevier, 2018, 536 (1), pp.116-126. ⟨10.1016/j.ijpharm.2017.11.049⟩. ⟨hal-02439838⟩
  • Thomas Secher, Isabelle Maillet, Claire Mackowiak, Jessica Le Bérichel, Amandine Philippeau, et al.. The probiotic strain Escherichia coli Nissle 1917 prevents papain-induced respiratory barrier injury and severe allergic inflammation in mice. Scientific Reports, Nature Publishing Group, 2018, 8 (1), ⟨10.1038/s41598-018-29689-9⟩. ⟨hal-02126575⟩
  • Thomas Secher, Sahar Kassem, Mehdi Benamar, Isabelle Bernard, Michele Boury, et al.. Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction. Frontiers in Immunology, Frontiers, 2017, 8, ⟨10.3389/fimmu.2017.01096⟩. ⟨hal-02624001⟩
  • David Reiss, R.A. Ceredig, Thomas Secher, J. Boué, Frédérick Barreau, et al.. Mu and delta opioid receptor knockout mice show increased colonic sensitivity. European Journal of Pain, Wiley, 2017, 21 (4), pp.623-634. ⟨10.1002/ejp.965⟩. ⟨hal-01607491⟩
  • Delphine Payros, Ulrich Dobrindt, Patricia Martin-Bizon, Thomas Secher, Ana Paula Bracarense, et al.. The food contaminant deoxynivalenol exacerbates the genotoxicity of gut microbiota. mBio, American Society for Microbiology, 2017, 8 (2), 11 p. ⟨10.1128/mBio.00007-17⟩. ⟨hal-01608529⟩
  • Haruyuki Nakayama-Imaohji, Katsuhiko Hirota, Hisashi Yamasaki, Saori Yoneda, Hirofumi Nariya, et al.. DNA Inversion Regulates Outer Membrane Vesicle Production in Bacteroides fragilis. PLoS ONE, Public Library of Science, 2016, 11 (2), pp.1-21. ⟨10.1371/journal.pone.0148887⟩. ⟨hal-02632202⟩
  • Thomas Secher, Camille Brehin, Eric Oswald. Early settlers: which E. coli strains do you not want at birth?. AJP - Gastrointestinal and Liver Physiology, American Physiological Society, 2016, 311 (1), pp.G123 - G129. ⟨10.1152/ajpgi.00091.2016⟩. ⟨hal-01602829⟩
  • Thomas Secher, Delphine Payros, Camille Brehin, Michèle Boury, Claude Watrin, et al.. Oral tolerance failure upon neonatal gut colonization with Escherichia coli producing the genotoxin colibactin. Infection and Immunity, American Society for Microbiology, 2015, 83 (6), pp.2420-2429. ⟨10.1128/IAI.00064-15⟩. ⟨hal-02634629⟩
  • Thomas Secher, Ayaka Shima, Karen Hinsinger, Jean Christophe Cintrat, Ludger Johannes, et al.. Retrograde trafficking inhibitor of Shiga toxins reduces morbidity and mortality of mice infected with enterohemorrhagic Escherichia coli. Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2015, 59 (8), pp.5010-5013. ⟨10.1128/AAC.00455-15⟩. ⟨hal-02640796⟩
  • D. Payros, T. Secher, M. Boury, C. Brehin, Sandrine Ménard, et al.. Maternally acquired genotoxic Escherichia coli alters offspring's intestinal homeostasis. Gut Microbes, 2014, 5 (3), pp.313-25. ⟨10.4161/gmic.28932⟩. ⟨hal-01859355⟩
  • Rodrigo Guabiraba, Anne-Gaëlle Besnard, Gustavo Batista Menezes, Thomas Secher, M. S. Jabir, et al.. IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice. Mucosal Immunology, Nature Pub. Group, 2014, 7 (5), pp.1079-1093. ⟨10.1038/mi.2013.124⟩. ⟨hal-02633989⟩
  • Thomas Secher, Sylvain Normand, Mathias Chamaillard. NOD2 prevents emergence of disease-predisposing microbiota. Gut microbes, Taylor & Francis, 2013, 4 (4), pp.353-356. ⟨10.4161/gmic.25275⟩. ⟨hal-02180087⟩
  • Sylvain Normand, Thomas Secher, Mathias Chamaillard. Dysbiosis, a new medical concept. médecine/sciences, EDP Sciences, 2013, 29 (6-7), pp.586-589. ⟨10.1051/medsci/2013296011⟩. ⟨hal-02180092⟩
  • Thomas Secher, Ascel Samba Louaka, Eric Oswald, Jean-Philippe Nougayrède. Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells. PLoS ONE, Public Library of Science, 2013, 8 (10), ⟨10.1371/journal.pone.0077157⟩. ⟨hal-02646496⟩
  • Bérengère Villeret, Lea Brault, Aurélie Couturier-Maillard, Pauline Robinet, Virginie Vasseur, et al.. Blockade of IL-1R signaling diminishes Paneth cell depletion and Toxoplasma gondii induced ileitis in mice. American journal of Clinical and Experimental Immunology, 2013, 2 (1), pp.107-116. ⟨hal-02651056⟩
  • Aurélie Couturier-Maillard, Thomas Secher, Ateequr Rehman, Sylvain Normand, Adèle de Arcangelis, et al.. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer.. Journal of Clinical Investigation, American Society for Clinical Investigation, 2013, 123 (2), pp.700-11. ⟨10.1172/JCI62236⟩. ⟨hal-00944194⟩
  • Maïwenn Olier, Ingrid Marcq, Christel Salvador Cartier, Thomas Secher, Ulrich Dobrindt, et al.. Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity. Gut microbes, Taylor & Francis, 2012, 3 (6), pp.501-509. ⟨10.4161/gutmicrobes.21737⟩. ⟨hal-02935516⟩
  • Thomas Secher, Olivier Gaillot, Bernhard Ryffel, Mathias Chamaillard. Remote control of intestinal tumorigenesis by innate immunity.. Cancer Research, American Association for Cancer Research, 2010, 70 (5), pp.1749-52. ⟨10.1158/0008-5472.CAN-09-3401⟩. ⟨hal-00591500⟩
  • Tatiana Victoni, Fernando Rodrigues Coelho, Alexandre Learth Soares, Andressa de Freitas, Thomas Secher, et al.. Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/MyD88 signaling pathway.. Medical Microbiology and Immunology, Springer Verlag, 2010, 199 (1), pp.35-42. ⟨10.1007/s00430-009-0134-5⟩. ⟨hal-00591521⟩
  • Kevin N Couper, Tom Barnes, Julius C R Hafalla, Valery Combes, Bernhard Ryffel, et al.. Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation.. PLoS Pathogens, Public Library of Science, 2010, 6 (1), pp.e1000744. ⟨10.1371/journal.ppat.1000744⟩. ⟨hal-00591502⟩
  • Andressa Freitas, José C Alves-Filho, Tatiana Victoni, Thomas Secher, Henrique P Lemos, et al.. IL-17 receptor signaling is required to control polymicrobial sepsis.. Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2009, 182 (12), pp.7846-54. ⟨10.4049/jimmunol.0803039⟩. ⟨hal-00404905⟩
  • Thomas Secher, Virginie Vasseur, Didier Marc Poisson, Jane A Mitchell, Fernando Q Cunha, et al.. Crucial role of TNF receptors 1 and 2 in the control of polymicrobial sepsis.. Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2009, 182 (12), pp.7855-64. ⟨10.4049/jimmunol.0804008⟩. ⟨hal-00404907⟩
  • R. Dessein, M. Gironella, Clémentine Vignal, L. Peyrin-Biroulet, H. Sokol, et al.. Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis.. Gut, BMJ Publishing Group, 2009, 58 (6), pp.771-6. ⟨10.1136/gut.2008.168443⟩. ⟨hal-00404858⟩
  • Laure Janot, Jean-Claude Sirard, Thomas Secher, Nicolas Noulin, Lizette Fick, et al.. Radioresistant cells expressing TLR5 control the respiratory epithelium's innate immune responses to flagellin.. European Journal of Immunology, Wiley-VCH Verlag, 2009, 39 (6), pp.1587-96. ⟨10.1002/eji.200838907⟩. ⟨inserm-00385299⟩
  • Laure Janot, Thomas Secher, David Torres, Isabelle Maillet, Josef Pfeilschifter, et al.. CD14 works with toll-like receptor 2 to contribute to recognition and control of Listeria monocytogenes infection.. Journal of Infectious Diseases, Oxford University Press (OUP), 2008, 198 (1), pp.115-24. ⟨10.1086/588815⟩. ⟨hal-00318570⟩
  • Jonathan Zalevsky, Thomas Secher, Sergei A Ezhevsky, Laure Janot, Paul M Steed, et al.. Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection.. Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2007, 179 (3), pp.1872-83. ⟨hal-00318488⟩
  • Dieudonnée Togbe, Silvia Schnyder-Candrian, Bruno Schnyder, Emilie Doz, Nicolas Noulin, et al.. Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury.. International Journal of Experimental Pathology, Wiley, 2007, 88 (6), pp.387-91. ⟨10.1111/j.1365-2613.2007.00566.x⟩. ⟨hal-00318537⟩

Conference papers1 document

  • Bruno Lamas, Nadine Waldschmitt, Sho Kitamoto, Thomas Secher, Vassiliki Zacharioudaki, et al.. A c-type lectin triggers immune surveillance by innate lymphoid cells for eradication of attaching-and-effacing bacteria. 25. United European Gastroenterology: Week, Oct 2017, Barcelone, Spain. ⟨hal-02786603⟩

Reports1 document

  • Thomas Secher. Réponses de suspensions cellulaires de pommier (Malus domestica) cultivées en présence d'Erwinia amylovora ou de differents eliciteurs. U.F.R. Sciences de la Vie. Université Pierre et Marie Curie - Paris 6 (UPMC), Paris, FRA. 1999, 20 p. ⟨hal-02841036⟩